Boletin 68 - Primer Cuatrimestre 2024

 
 
 
 
 

NOTICIAS

CAT 's

Nuevas Evidencias

Arsh A, Afaq S, et al. Effectiveness of physical activity in managing co-morbid depression in adults with type 2 diabetes mellitus: A systematic review and meta-analysis. J Affect Disord. 2023;329: 448–459. https://doi.org/10.1016/j.jad.2023.02.122

 

Bennett S, Robb KA, et al. Male suicide risk and recovery factors: A systematic review and qualitative meta-synthesis of two decades of research. Psychological Bulletin 2023, 149(7-8), 371–417.

 

Diamond R, Waite F, Boylan A, et al. Framework for understanding movement and physical activity in patients diagnosed with psychosis. BMJ Ment Health 2024;27:e300878

 

Duffy L, Lewis G, Marston L, et al. Clinical factors associated with relapse in depression in a sample of UK primary care patients who have been on long-term antidepressant treatment. Psychological Medicine 2023, 1-11.

 

Efthimiou O, Taipale H, et al. Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. The Lancet. Psychiatry, 2024 Feb;11(2):102-111. doi: 10.1016/S2215-0366(23)00366-8.

 

Faiman I, Hodsoll J, Jasani I, et al. Sociodemographic and clinical risk factors for suicidal ideation and suicide attempt in functional/dissociative seizures and epilepsy: a large cohort study. BMJ Ment Health 2024; 27:e300957

 

Hamard J, Rousseau V, Durrieu G, et al. Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults. BMJ Ment Health 2024;27:e300876.

 

Kamp CB, Petersen JJ, Faltermeier P, et al. Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis. BMJ Ment Health 2024;27:e300730.

 

Mok PLH, Carr MJ, Guthrie B, et al. Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. BMJ. 2024 Apr 17;385:e076268. doi: 10.1136/bmj-2023-076268.

 

NICE. 2024. Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment. Health technology evaluation [HTE17]. Published: 25 March 2024

 

NICE. 2024. Digitally enabled therapies for adults with depression: early value assessment.

Health technology evaluation [HTE8]. Published: 16 May 2023. Last updated: 12 February 2024.

 

Pearce M, Garcia L, Abbas A, et al. Association Between Physical Activity and Risk of Depression: A Systematic Review and Meta-analysis. JAMA Psychiatry 2023, 79(6), 550–559. https://doi.org/10.1001/jamapsychiatry.2022.0609

 

Seyedsalehi A, Fazel S. Suicide risk assessment tools and prediction models: new evidence, methodological innovations, outdated criticisms. BMJ Ment Health 2024; 27:e300990.

 

Thompson R, Lawrance EL, Roberts LF, et al. (2023). Ambient temperature and mental health: A systematic review and meta-analysis. The Lancet Planetary Health 2023, 7(7), e580-e589.

 

Valentine AZ, Hall SS, Sayal K, et al. Waiting-list interventions for children and young people using child and adolescent mental health services: a systematic review. BMJ Ment Health 2024; 27:e300844.

 

Vöckel J, Markser A. et al. Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: A systematic-review and meta-analysis. Eur Neuropsychopharmacol. 2024 78:16-29